SOPHIA BIOSCIENCE
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers. It aims to increase the effectiveness of established drugs while lowering their required dosage and minimizing side effects. Sophia Bioscience also works to improve the drug development process, shortening the time to develop and significantly lowering associated costs. The company is currently focused on treating prostate cancer. The first drug candidate Sophia has put forward uses an independent anti-tumor chemotype, HDACi, and exploits prostate tumor androgen receptors (AR) for a more selective delivery than existing drugs. By exploiting these receptors, the drug resolves the issue of insufficient accumulation in the tumor and localizes the effects of the HDACi.
SOPHIA BIOSCIENCE
Industry:
Biotechnology Health Care Life Science Therapeutics
Status:
Active
Total Funding:
59.17 K USD
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Sophia Bioscience
More informations about "Sophia Bioscience"
Sophia Bioscience - Crunchbase Company Profile & Funding
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers. It aims to increase the effectiveness of established drugs while lowering their required dosage …See details»
Home - SOFIE
Trilantic North America Completes Strategic Growth Investment in SOFIE Biosciences Patrick Phelps 2024-06-03T20:17:45+00:00 [18F]FAPI-74 serving as complementary diagnostic in …See details»
Sophia Bioscience - Funding, Financials, Valuation & Investors
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers.See details»
Sophia Bioscience Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sophia Bioscience Inc of Marietta, GA. Get the latest business insights from Dun & Bradstreet.See details»
Sophia Bioscience - Crunchbase
Sophia Bioscience, Migra Therapeutics, Amorsa Therapeutics, New Echota Biotechnology, Phagotherapy LAB, and SpaceM are all involved in the biotechnology and pharmaceutical …See details»
Who We Are - SOFIE
Apr 25, 2021 Our mission is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). With a robust radiopharmaceutical production and distribution network, mature contract …See details»
SOPHiA GENETICS - Where others see data we see …
Retain ownership of your data. SOPHiA DDMâ„¢: A universal healthcare analytics platform. Powered by AI and machine learning (ML), our global cloud-based platform provides a safe, secure, and instantly accessible environment to …See details»
Georgia Research Alliance - GRA
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers. The company aims to increase the effectiveness of established drugs while lowering their required …See details»
Team - SOFIE
Our team works alongside our Pharma and Academic partners to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease.See details»
Sophia Genetics - Wikipedia
The company has been through multiple rounds of funding. In September 2013, as part of a Series A round of funding, Sophia Genetics received $3 million for its medical software …See details»
Investor Relations | SOPHiA GENETICS, Inc. - Corporate …
At SOPHiA GENETICS, we are bringing the power of data and artificial intelligence to healthcare. Our AI platform analyzes multimodal data - including genomics, radiomics, clinical, biological, and digital pathology data - to …See details»
Sophia Genetics to Collaborate with GE Healthcare to Advance …
Jul 8, 2021 This collaboration adds to a number of others made by Sophia, including with Hitachi earlier this year, and MGI and Twist Biosciences, last year, among others. Sophia has also …See details»
Sophia Bioscience - Tech Stack, Apps, Patents & Trademarks
Organization. Sophia Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by …See details»
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand …
Sep 10, 2024 The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months. BOSTON and ROLLE, Switzerland, September 10, 2024– …See details»
Research programme: prostate cancer therapeutics - Sophia …
Sophia Bioscience is developing therapeutics for the treatment of prostate cancer. Development is at the preclinical stage in the US. Research programme: prostate cancer therapeutics - Sophia …See details»
OncoDNA teams up with SOPHiA GENETICS to enable laboratories …
Sept. 30, 2021. For the use with SOPHiA DDMâ„¢ to match tumor genomic profiles with targeted therapies. OncoDNA, a genomic and theranostic company specializing in precision medicine …See details»
Sophia Genetics - MIT Technology Review
Sophia Genetics uses AI algorithms to sort through patients’ DNA sequences in an attempt to diagnose cancer and other illnesses more quickly. The company’s business model is to charge ...See details»
Sophia Bioscience - Updates, News, Events, Signals & Triggers
Edit Recent News & Activity Section. Funding Round • Feb 6, 2017. Sophia Bioscience raised $59,170 / Grant from Georgia Research Alliance raised $59,170 / Grant from Georgia …See details»
SOPHiA GENETICS Unveils Strategy to Drive Health Care …
Sep 21, 2022 SOPHiA DDMâ„¢ Dx Myeloid Solution and SOPHiA DDMâ„¢ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in Europe, Turkey and …See details»
Sophie Bai Creates Scientific Breakthroughs for Her Skincare …
Mar 13, 2024 Sophie Bai is a scientist, founder of biotech company B.A.I. Biosciences—and a beauty and skincare wunderkind. The 33-year-old uses her background in the biomedical …See details»